What it is
Regulatory status: dietary supplement; not an FDA-approved treatment
Evidence basis: Human clinical evidence
Curcuminoids affect inflammatory signaling in laboratory models; phytosome delivery increases exposure compared with unformulated curcumin. Clinical outcomes remain product- and indication-specific.
What it is, why people use it, the evidence, and what to know before trying it.
Regulatory status: dietary supplement; not an FDA-approved treatment
Evidence basis: Human clinical evidence
Known side effects, interactions and use limits from reviewed sources.
Gastrointestinal upset can occur. Curcumin products may affect bleeding risk and gallbladder symptoms; formulations that change absorption should not be assumed equivalent.
This review does not automatically apply to:
Public protocols that include Curcumin phytosome. Open one to see the full context and source.
Dose not stated. Random Show
Brand variants reported in public protocols. Private entries are excluded, and inclusion is not an endorsement.
Continue into interventions that appear alongside this one.